DK1140175T3 - Antistoffer mod trunkeret VEGF-D og anvendelser deraf - Google Patents
Antistoffer mod trunkeret VEGF-D og anvendelser derafInfo
- Publication number
- DK1140175T3 DK1140175T3 DK99969995T DK99969995T DK1140175T3 DK 1140175 T3 DK1140175 T3 DK 1140175T3 DK 99969995 T DK99969995 T DK 99969995T DK 99969995 T DK99969995 T DK 99969995T DK 1140175 T3 DK1140175 T3 DK 1140175T3
- Authority
- DK
- Denmark
- Prior art keywords
- vegf
- antibodies against
- antibodies
- vegfr
- interfere
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11325498P | 1998-12-21 | 1998-12-21 | |
US13455699P | 1999-05-17 | 1999-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1140175T3 true DK1140175T3 (da) | 2006-08-14 |
Family
ID=26810852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99969995T DK1140175T3 (da) | 1998-12-21 | 1999-12-21 | Antistoffer mod trunkeret VEGF-D og anvendelser deraf |
Country Status (13)
Country | Link |
---|---|
US (3) | US6383484B1 (de) |
EP (1) | EP1140175B1 (de) |
JP (1) | JP4632543B2 (de) |
KR (1) | KR20010081089A (de) |
CN (1) | CN1330555A (de) |
AT (1) | ATE322909T1 (de) |
AU (2) | AU770332B2 (de) |
CA (1) | CA2355896A1 (de) |
DE (1) | DE69930872T8 (de) |
DK (1) | DK1140175T3 (de) |
ES (1) | ES2259247T3 (de) |
PT (1) | PT1140175E (de) |
WO (1) | WO2000037025A2 (de) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6824777B1 (en) | 1992-10-09 | 2004-11-30 | Licentia Ltd. | Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
ATE459715T1 (de) * | 1995-09-29 | 2010-03-15 | Univ Siena | Regulierte gene und ihre verwendungen |
DK2107109T3 (da) | 1996-08-23 | 2012-09-24 | Vegenics Pty Ltd | Rekombinant vaskulær endotelcelle-vækstfaktor D (VEGF-D) |
US7125714B2 (en) | 1997-02-05 | 2006-10-24 | Licentia Ltd. | Progenitor cell materials and methods |
US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2000058511A1 (en) | 1999-03-26 | 2000-10-05 | Ludwig Institute For Cancer Research | Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
AU783683B2 (en) * | 2000-01-18 | 2005-11-24 | Vegenics Limited | VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
ATE377081T1 (de) * | 2000-02-25 | 2007-11-15 | Ludwig Inst Cancer Res | Material und verfahren die hybridvaskularendothelwachstumfaktoren dns und proteine enthalten und screeningverfahren für modulatoren |
US20020102260A1 (en) | 2000-03-02 | 2002-08-01 | Marc Achen | Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue |
WO2001064235A1 (en) * | 2000-03-02 | 2001-09-07 | Ludwig Institute For Cancer Research | Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d |
EP1299419A2 (de) * | 2000-05-24 | 2003-04-09 | Imclone Systems, Inc. | Bispezifische immunglobulinartige antigenbindende proteine und verfahren zur deren herstellung |
US7611711B2 (en) * | 2001-01-17 | 2009-11-03 | Vegenics Limited | VEGFR-3 inhibitor materials and methods |
CN1494552A (zh) | 2001-01-19 | 2004-05-05 | ·��ά��֢�о�Ժ | Flt4(VEGFR-3)作为靶用于肿瘤成像和抗肿瘤治疗 |
WO2002064097A2 (en) * | 2001-02-12 | 2002-08-22 | The Penn State Research Foundation | Vegf-d expression in brain cancer |
DK1385864T3 (da) * | 2001-04-13 | 2010-08-16 | Human Genome Sciences Inc | Anti-VEGF-2-antistoffer |
US20050232921A1 (en) * | 2001-04-13 | 2005-10-20 | Rosen Craig A | Vascular endothelial growth factor 2 |
US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
CN100497389C (zh) | 2001-06-13 | 2009-06-10 | 根马布股份公司 | 表皮生长因子受体(egfr)的人单克隆抗体 |
EP1411983A4 (de) * | 2001-06-26 | 2006-06-21 | Imclone Systems Inc | Bispezifische antikörper, die an vegf-rezeptoren binden |
JP2005500045A (ja) * | 2001-07-12 | 2005-01-06 | ルードビッヒ、インスティテュート、フォー、キャンサー、リサーチ | リンパ管内皮細胞材料および方法 |
US20030113324A1 (en) * | 2001-10-01 | 2003-06-19 | Kari Alitalo | Neuropilin/VEGF-C/VEGFR-3 materials and methods |
US20040214766A1 (en) * | 2001-10-01 | 2004-10-28 | Kari Alitalo | VEGF-C or VEGF-D materials and methods for treatment of neuropathologies |
AU2003252039A1 (en) | 2002-07-23 | 2004-02-09 | Vegenics Limited | Methods and compositions for activating or inhibiting vegf-d and vegf-c |
US7608684B2 (en) * | 2002-11-12 | 2009-10-27 | Mochida Pharmaceuticals Co., Ltd. | Soluble CD14 antigen |
CN100558746C (zh) * | 2002-11-12 | 2009-11-11 | 持田制药株式会社 | 人低分子量cd14测定试剂盒和抗体 |
DE10256410B3 (de) * | 2002-12-02 | 2004-03-11 | Daimlerchrysler Ag | Verfahren zum Energiemanagement von Klimaanlagen |
US20040120950A1 (en) * | 2002-12-20 | 2004-06-24 | Kari Alitalo | Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis |
WO2004070018A2 (en) * | 2003-02-04 | 2004-08-19 | Ludwig Institute For Cancer Research | Vegf-b and pdgf modulation of stem cells |
WO2005016963A2 (en) * | 2003-06-12 | 2005-02-24 | Ludwig Institute For Cancer Research | Heparin binding veger-3 ligands |
US20050043235A1 (en) * | 2003-06-12 | 2005-02-24 | Kari Alitalo | Use of VEGF-C or VEGF-D in reconstructive surgery |
DK1660057T3 (da) | 2003-08-27 | 2012-08-20 | Ophthotech Corp | Kombinationsterapi til behandling af neovaskulære øjenlidelser |
US20060024302A1 (en) * | 2004-03-05 | 2006-02-02 | Ludwig Institute For Cancer Research | Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same |
WO2005087812A1 (en) * | 2004-03-05 | 2005-09-22 | Ludwig Institute For Cancer Research | Multivalent antibody materials and methods for vegf/pdgf family of growth factors |
US7595149B1 (en) | 2004-11-08 | 2009-09-29 | University Of Kentucky Research Foundation | Methods for cancer detection |
TWI428143B (zh) * | 2006-01-18 | 2014-03-01 | Gen Hospital Corp | 增加淋巴功能之方法 |
US7667880B2 (en) * | 2006-02-10 | 2010-02-23 | Adobe Systems, Incorporated | Method and apparatus for previewing digital motion picture content |
US9073997B2 (en) * | 2007-02-02 | 2015-07-07 | Vegenics Pty Limited | Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis |
AR066660A1 (es) * | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
DE102007038730A1 (de) * | 2007-08-16 | 2009-02-19 | Carl Zeiss Meditec Ag | Nachweis des menschlichen Vascular Endothelial Growth Factor |
CN101245106B (zh) * | 2007-12-04 | 2011-07-20 | 澳赛尔斯生物技术(上海)有限公司 | 抗vegf受体单克隆抗体及其制备方法和应用 |
US7811776B2 (en) * | 2007-12-05 | 2010-10-12 | University Of Cincinnati | Use of VEGF-D in the diagnosis of lymphangioleiomyomatosis (LAM) disease |
WO2009143584A1 (en) * | 2008-05-30 | 2009-12-03 | Vegenics Limited | Treatment of pulmonary edema |
SG10201510586PA (en) | 2008-06-30 | 2016-01-28 | Mesoblast Inc | Treatment of Eye Diseases And Excessive Neovascularization Using A Combined Therapy |
US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
US8968210B2 (en) | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
CA2751445C (en) * | 2009-02-06 | 2018-06-19 | Pepscan Systems B.V. | Truncated cystine-knot proteins |
CN102448494B (zh) | 2009-02-13 | 2016-02-03 | 免疫医疗公司 | 具有胞内可裂解的键的免疫共轭物 |
WO2010111746A1 (en) * | 2009-04-03 | 2010-10-07 | Vegenics Limited | Anti-vegf-d antibodies |
CA2774260C (en) | 2009-09-16 | 2018-10-09 | Immunomedics, Inc. | Class i anti-cea antibodies and uses thereof |
CA2782194C (en) | 2009-12-02 | 2018-01-16 | Immunomedics, Inc. | Combination of radiolabelled antibodies (rait) and antibody-drug conjugates (adc) for treatment of pancreatic cancer |
WO2011106697A1 (en) | 2010-02-25 | 2011-09-01 | Schepens Eye Research Institute | Therapeutic compositions for the treatment of dry eye disease |
JP6024025B2 (ja) | 2011-05-02 | 2016-11-09 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | 少容量投与用のアロタイプ選択抗体の限外濾過濃縮 |
CA2874864C (en) | 2012-08-14 | 2023-02-21 | Ibc Pharmaceuticals, Inc. | T-cell redirecting bispecific antibodies for treatment of disease |
PL2900277T3 (pl) | 2012-12-13 | 2022-05-16 | Immunomedics, Inc. | Dawkowanie immunokoniugatów przeciwciał i sn-38 dla poprawy skuteczności i zmniejszenia toksyczności |
WO2017004144A1 (en) | 2015-07-01 | 2017-01-05 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
WO2014124487A1 (en) | 2013-02-18 | 2014-08-21 | Vegenics Pty Limited | Ligand binding molecules and uses thereof |
KR20230152151A (ko) | 2013-07-12 | 2023-11-02 | 이베릭 바이오, 인크. | 안과적 질환을 치료하거나 예방하기 위한 방법 |
WO2015126548A1 (en) | 2014-02-21 | 2015-08-27 | Ibc Pharmaceuticals, Inc. | Disease therapy by inducing immune response to trop-2 expressing cells |
WO2015130416A1 (en) | 2014-02-25 | 2015-09-03 | Immunomedics, Inc. | Humanized rfb4 anti-cd22 antibody |
CA2953567C (en) | 2014-06-24 | 2023-09-05 | Immunomedics, Inc. | Anti-histone therapy for vascular necrosis in severe glomerulonephritis |
CN106999517A (zh) | 2014-10-07 | 2017-08-01 | 免疫医疗公司 | 抗体‑药物缀合物的新辅助剂用途 |
JP6746845B2 (ja) | 2015-04-22 | 2020-08-26 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | 循環trop−2陽性癌細胞の単離、検出、診断及び/または特徴付け |
CN107735104B (zh) | 2015-06-25 | 2022-05-03 | 免疫医疗公司 | 组合抗hla-dr抗体或抗trop-2抗体与微管抑制剂、parp抑制剂、布鲁顿激酶抑制剂或磷酸肌醇3-激酶抑制剂使癌症治疗结果显著改善 |
AU2017217677A1 (en) | 2016-02-08 | 2018-07-26 | Vitrisa Therapeutics, Inc. | Compositions with improved intravitreal half-life and uses thereof |
CN108794629A (zh) * | 2018-06-28 | 2018-11-13 | 浙江众意生物科技有限公司 | 一种vegf-d单克隆抗体及试剂盒 |
EP4342497A1 (de) | 2021-05-10 | 2024-03-27 | Kawasaki Institute of Industrial Promotion | Antikörper mit reduzierter bindungsaffinität für antigen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998033917A1 (en) * | 1994-11-14 | 1998-08-06 | The Ludwig Institute For Cancer Research | Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
AU733322B2 (en) * | 1996-07-15 | 2001-05-10 | Chugai Seiyaku Kabushiki Kaisha | Novel VEGF-like factor |
DK2107109T3 (da) * | 1996-08-23 | 2012-09-24 | Vegenics Pty Ltd | Rekombinant vaskulær endotelcelle-vækstfaktor D (VEGF-D) |
WO1998024811A2 (en) * | 1996-12-06 | 1998-06-11 | Zymogenetics, Inc. | Vascular endothelial growth factor |
CN1345247A (zh) * | 1997-12-24 | 2002-04-17 | 路德维格癌症研究所 | 表达血管内皮生长因子d的表达载体和细胞系以及治疗黑素瘤的方法 |
BR0010017A (pt) * | 1999-04-28 | 2002-06-11 | Univ Texas | Composições e processos para o tratamento de câncer por inibição seletiva de vegf |
-
1999
- 1999-12-21 ES ES99969995T patent/ES2259247T3/es not_active Expired - Lifetime
- 1999-12-21 DE DE69930872T patent/DE69930872T8/de active Active
- 1999-12-21 KR KR1020017007826A patent/KR20010081089A/ko not_active Application Discontinuation
- 1999-12-21 WO PCT/US1999/031332 patent/WO2000037025A2/en not_active Application Discontinuation
- 1999-12-21 AT AT99969995T patent/ATE322909T1/de not_active IP Right Cessation
- 1999-12-21 CA CA002355896A patent/CA2355896A1/en not_active Abandoned
- 1999-12-21 AU AU33432/00A patent/AU770332B2/en not_active Ceased
- 1999-12-21 PT PT99969995T patent/PT1140175E/pt unknown
- 1999-12-21 CN CN99814571A patent/CN1330555A/zh active Pending
- 1999-12-21 DK DK99969995T patent/DK1140175T3/da active
- 1999-12-21 US US09/469,186 patent/US6383484B1/en not_active Expired - Lifetime
- 1999-12-21 JP JP2000589139A patent/JP4632543B2/ja not_active Expired - Fee Related
- 1999-12-21 EP EP99969995A patent/EP1140175B1/de not_active Expired - Lifetime
-
2002
- 2002-03-19 US US10/100,037 patent/US6730489B1/en not_active Expired - Fee Related
-
2004
- 2004-02-18 US US10/779,731 patent/US7097986B2/en not_active Expired - Fee Related
- 2004-05-17 AU AU2004202080A patent/AU2004202080A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002532113A (ja) | 2002-10-02 |
DE69930872T2 (de) | 2006-11-30 |
CN1330555A (zh) | 2002-01-09 |
AU3343200A (en) | 2000-07-12 |
JP4632543B2 (ja) | 2011-02-16 |
DE69930872T8 (de) | 2007-05-03 |
US6383484B1 (en) | 2002-05-07 |
US20040141917A1 (en) | 2004-07-22 |
WO2000037025A2 (en) | 2000-06-29 |
EP1140175B1 (de) | 2006-04-12 |
AU2004202080A1 (en) | 2004-06-10 |
DE69930872D1 (de) | 2006-05-24 |
CA2355896A1 (en) | 2000-06-29 |
PT1140175E (pt) | 2006-06-30 |
ATE322909T1 (de) | 2006-04-15 |
ES2259247T3 (es) | 2006-09-16 |
US6730489B1 (en) | 2004-05-04 |
AU770332B2 (en) | 2004-02-19 |
KR20010081089A (ko) | 2001-08-25 |
EP1140175A4 (de) | 2003-03-05 |
EP1140175A2 (de) | 2001-10-10 |
US7097986B2 (en) | 2006-08-29 |
WO2000037025A3 (en) | 2000-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1140175T3 (da) | Antistoffer mod trunkeret VEGF-D og anvendelser deraf | |
DE69840195D1 (de) | Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1 | |
TR201708554T4 (tr) | Masp-2 ye bağlı tamamlayıcı aktivasyon ile ilişkili durumların tedavisi için yöntemler. | |
NO942750L (no) | Monomere og dimere fusjonsproteiner av antistoff-fragment | |
DK0724456T3 (da) | CD40-Antistoffer | |
ATE178907T1 (de) | Rezeptorbindende region des diphtherietoxius | |
NO20000934D0 (no) | Adipocyttspesifikke proteinhomologer | |
DE69232309D1 (de) | Weitgehend reine rezeptorartige, tgf-beta-1-bindende moleküle und deren verwendungen | |
DE69834828D1 (de) | Verfahren zur konstruktion von agonisten und antagonisten des igf-rezeptors (1-462) | |
ATE302274T1 (de) | Methoden zur bestimmung von komponenten zur modulation des körpergewichts | |
ATE327328T1 (de) | Adipozyten-spezifische protein homologe | |
NO986088D0 (no) | Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisi | |
DE69535855D1 (de) | Calciumbindende rekombinante antikörper gegen protein c | |
CY1108568T1 (el) | Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α | |
EE05497B1 (et) | Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha | |
WO1995011975A3 (en) | Retroviral superantigens, superantigen peptides, and methods of use | |
DK0901526T3 (da) | Cortistatin: neuropeptider, sammensætninger og metoder | |
ATE132162T1 (de) | Humane gammainterferonantagonisten | |
ES2072868T3 (es) | Proteina capaz de unir la fibronectina y su preparacion. | |
DE59508137D1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
NO970113L (no) | Kollagenbindende protein eller polypeptid | |
DE69831084D1 (de) | Beta-defensine | |
DK0889907T3 (da) | Monoklonale antistoffer, som binder humant væksthormon (hGH) | |
EE9900272A (et) | Uudsed IFN-retseptoriga 1 seonduvad valgud, neid kodeeriv DNA ja interferoonidele suunatud raku vastuse moduleerimise meetodid | |
BRPI0216042B8 (pt) | polipeptídeo capaz de se ligar a ang-2, vetor de expressão, célula hospedeira, composição farmacêutica, e, uso dos referidos polipeptídeos. |